Axmed seeks to address the dire challenge of drug supply chain fragmentation by connecting manufacturers with health institutions to reduce inefficiencies, shortages, high costs, and counterfeit drugs.
Operating in countries like Kenya, Nigeria, Ethiopia, Tanzania, and Rwanda, Axmed targets key stakeholders such as faith-based institutions, NGOs, government care providers, and procurement agencies.
Emmanuel Akpakwu, Axmed's CEO, aims to leverage the aggregation model to empower buyers and enhance market opportunities for manufacturers, drawing from his experience at Novartis.
#b2b-marketplace #seed-funding #drug-supply-chains #healthcare-accessibility #manufacturer-connections
[
add
]
[
|
|
...
]